Neoadjuvant chemoradiotherapy plus sintilimab in proficient mismatch repair locally advanced rectal cancer with intermediate/high-immunoscore (SILAR): a single-arm phase II trial
新辅助放化疗联合信迪利单抗治疗中/高免疫评分(SILAR)的错配修复功能正常的局部晚期直肠癌:一项单臂II期临床试验
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-65162-8
Zheng, Xiaobin; Liu, Huashan; Shi, Lishuo; Zeng, Ziwei; Zhang, Xingwei; Luo, Shuangling; Cai, Yonghua; Li, Ze; Liu, Zhanzhen; Hou, Yujie; Yang, Zuli; He, Xiaowen; Ke, Jia; Huang, Liang; Luo, Yanxin; Kang, Liang